Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Your doctor might need blood and urine tests to check for unwanted effects
9 is an ally for users of GLP-1s who may experience GI discomforts such as nausea, indigestion, and/or sluggish bowel function
Quick Specs Form: Lyophilized powder (white to off-white) Purity: 99% by HPLC every batch Identity: MS molecular-weight confirmed every batch CAS Number: 2381089-83-2 Also Known As: LY3437943, triple incretin agonist Sequence Length: 39 amino acids Molecular Formula: C228H350N48O66 (confirm per COA) Molecular Weight: ~4731 Da (confirm per COA) Receptor Targets: GIPR + GLP-1R + GCGR Modification: Fatty-diacid side chain (albumin binding) Half-Life: ~6 days (research literature) Peptide Type: Synthetic triple incretin receptor agonist COA: Janoshik third-party publicly verifiable Manufacture: Lyophilized & QC-released in-house Storage: 20C sealed | 28C reconstituted Shelf Life: 24 months unopened (lyophilized) Certificate of Analysis Janoshik ThirdParty Verification Every batch is independently tested by Janoshik
We didnt measure circadian effects directly in the SURMOUNT-OSA trial, but its a potential mechanism worth exploring in future studies. Researchers are also investigating the potential for GLP-1s to affect rapid eye movement (REM) sleep, the phase of sleep associated with memory consolidation and emotional regulation
Interestingly, intravenous injections of glutathione have been used for years but there is not even a single clinical trial evaluating its efficacy
Synchronous care involves a real-time video or phone visit with a licensed clinician
